Base editing screens map mutations affecting IFNg signalling in cancer

Matt is a postdoctoral researcher in the Garnett laboratory at the Wellcome Sanger Institute, Cambridge, UK. His research is focused on functional genomics strategies to understand molecular pathways involved in sensitivity to cancer immunotherapies. Matt has gained prior expertise in cancer immunotherapy in the laboratory of Julian Downward at the Francis Crick Institute, and CRISPR and base editing technologies at AstraZeneca.